<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726753/" ref="ordinalpos=3608&amp;ncbi_uid=5168260&amp;link_uid=PMC3726753" image-link="/pmc/articles/PMC3726753/figure/pone-0068985-g003/" class="imagepopup">Figure 3. Morphoproteomic analysis of insulin-like growth factor(IGF) <span class="highlight" style="background-color:">pathway</span>..  From: Morphoproteomic Profiling of the Mammalian Target of Rapamycin (mTOR) <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> in Desmoplastic Small Round Cell Tumor (EWS/WT1), Ewing's Sarcoma (EWS/FLI1) and Wilms' Tumor(WT1). </a></div><br /><div class="p4l_captionBody">Morphoproteomic analysis of insulin-like growth factor(IGF) pathway reveals constitutive activation of IGF-1receptor as evidenced by the expression of phosphorylated (p)-IGF-1R (Tyr1165/1166) on the plasmalemmal aspect and in cytoplasmic compartments of the tumor cells in DSCRT (Patient #1). Note overexpression vis-à-vis the tumoral stroma (original magnification ×400).</div></div>